![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
North China Pharmaceutical Group Semisyntech Co., Ltd. Shijiazhuang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ampicillin trihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2009-321 - Rev 01
This Chemical Type CEP, issued on September 17, 2019, remains in force until January 10, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 168 associated with this CEP further emphasizes